GREENWICH, Conn., June 4, 2026 /PRNewswire/ -- National Kidney Registry (NKR) is pleased to announce the nationwide rollout of the StrongBox®. The StrongBox® is a...
Together, IDEMIA Public Security and Nevetal are shaping the next generation of digital journeys across the cruise ecosystem.COURBEVOIE, France, June 4, 2026 /PRNewswire/ --...
EcoVadis score rises to 87/100, reflecting a decade-long sustainability journey and reinforcing Aarti's position among the world's leading sustainability performers.MUMBAI, India, June 4, 2026...
Data center industry veteran to oversee development, product strategy, and service delivery as Flexential accelerates nationwide growthDENVER, June 4, 2026 /PRNewswire/ -- Flexential, a...
Newest wave of consumer sentiment research reveals 73% of Americans are cutting nonessential spending while consumers grow more skeptical, cautious and deliberate about purchase...
Annex Brands, Inc. Supports Local Entrepreneurs in Sustaining Essential Shipping and Office ServicesSAN DIEGO, June 4, 2026 /PRNewswire/ -- Annex Brands, Inc., a leading franchisor...
Securing this CE mark expands access to the HydroMARK™ Plus markers across Europe, combining proprietary hydrogel technology with features designed to support marker stability...
Industry-academia collaboration brings hands-on AI learning and real-world technology exposure to students across three campusesCOIMBATORE, India, June 4, 2026 /PRNewswire/ -- Orion Innovation ("Orion"), a...
Zydus Hospitals Ahmedabad and Vadodara reach new heights in advanced transplant care AHMEDABAD, India, June 4, 2026 /PRNewswire/ -- Organ transplantation in India has come a...
The Forums will equip business and technology leaders with the frameworks and insights needed to scale AI and deliver measurable outcomesSINGAPORE, June 4, 2026...
Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. The findings, based on a documented Canadian patient case and supporting clinical research, highlight how cross-border treatment pathways may provide patients with aggressive brain tumors access to individualized immunotherapy options that are not widely available within all healthcare systems.